Morgan Stanley’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-134,401
Closed -$2.47M 7694
2020
Q4
$2.47M Buy
134,401
+82,746
+160% +$1.52M ﹤0.01% 3971
2020
Q3
$948K Buy
51,655
+44,299
+602% +$813K ﹤0.01% 4243
2020
Q2
$110K Buy
7,356
+3,120
+74% +$46.7K ﹤0.01% 5364
2020
Q1
$67K Sell
4,236
-15,749
-79% -$249K ﹤0.01% 5355
2019
Q4
$325K Buy
19,985
+13,188
+194% +$214K ﹤0.01% 5165
2019
Q3
$101K Buy
6,797
+5,358
+372% +$79.6K ﹤0.01% 5446
2019
Q2
$23K Sell
1,439
-1,796
-56% -$28.7K ﹤0.01% 5894
2019
Q1
$55K Sell
3,235
-16,806
-84% -$286K ﹤0.01% 5625
2018
Q4
$354K Sell
20,041
-250
-1% -$4.42K ﹤0.01% 5011
2018
Q3
$369K Sell
20,291
-5,797
-22% -$105K ﹤0.01% 5154
2018
Q2
$510K Buy
26,088
+10,850
+71% +$212K ﹤0.01% 5088
2018
Q1
$267K Buy
15,238
+13,938
+1,072% +$244K ﹤0.01% 5348
2017
Q4
$15K Hold
1,300
﹤0.01% 6152
2017
Q3
$14K Sell
1,300
-4,997
-79% -$53.8K ﹤0.01% 6116
2017
Q2
$55K Sell
6,297
-10,974
-64% -$95.9K ﹤0.01% 5826
2017
Q1
$203K Sell
17,271
-19,421
-53% -$228K ﹤0.01% 5326
2016
Q4
$481K Buy
36,692
+34,468
+1,550% +$452K ﹤0.01% 4956
2016
Q3
$32K Buy
2,224
+2,174
+4,348% +$31.3K ﹤0.01% 5762
2016
Q2
$1K Sell
50
-46
-48% -$920 ﹤0.01% 6461
2016
Q1
$2K Sell
96
-108
-53% -$2.25K ﹤0.01% 6423
2015
Q4
$4K Sell
204
-1,059
-84% -$20.8K ﹤0.01% 6427
2015
Q3
$21K Buy
1,263
+473
+60% +$7.87K ﹤0.01% 6042
2015
Q2
$30K Sell
790
-5,539
-88% -$210K ﹤0.01% 6026
2015
Q1
$199K Buy
6,329
+6,296
+19,079% +$198K ﹤0.01% 5208
2014
Q4
$0 Sell
33
-3,131
-99% ﹤0.01% 6736
2014
Q3
$66K Buy
+3,164
New +$66K ﹤0.01% 5634